Literature DB >> 12487823

Rapid disease progression in human immunodeficiency virus type 1-infected seroconverters in India.

Sanjay M Mehendale1, Robert C Bollinger, Smita S Kulkarni, Rebecca Y Stallings, Ronald S Brookmeyer, Sangita V Kulkarni, Anand D Divekar, Raman R Gangakhedkar, Smita N Joshi, Arun R Risbud, Madhuri A Thakar, Bharati A Mahajan, Varsha A Kale, Manisha V Ghate, Deepak A Gadkari, Thomas C Quinn, Ramesh S Paranjape.   

Abstract

To determine if the early immunological and virological events of HIV infection are unique in a setting with limited access to health care and HIV-1 subtype C infection, we undertook a prospective cohort study to characterize the early natural history of HIV viral load and CD4(+) T lymphocyte counts in individuals with recent HIV seroconversion in India. CD4(+) T lymphocyte counts were prospectively measured for up to 720 days in 46 antiviral drug-naive persons with very early HIV infection, documented by HIV antibody seroconversion. HIV viral RNA levels were measured subsequently on reposited plasma samples from these same time points. The median viral load "set point" for Indian seroconverters was 28,729 RNA copies/ml. The median CD4(+) cell count following acute primary HIV infection was 644 cells/mm(3). Over the first 2 years since primary infection, the annual rate of increase in HIV viral load was +8274 RNA copies/ml/year and the annual decline in CD4 cell count was -120 cells/year. Although the viral "set point" was similar, the median trajectory of increasing viral load in Indian seroconverters was greater than what has been reported in untreated HIV seroconverters in the United States. These data suggest that the more rapid HIV disease progression described in resource-poor settings may be due to very early virological and host events following primary HIV infection. A rapid increase in viral load within the first 2 years after primary infection may have to be considered when applying treatment guidelines for antiretroviral therapy and opportunistic infection prophylaxis.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12487823     DOI: 10.1089/08892220260387913

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN: 0889-2229            Impact factor:   2.205


  12 in total

1.  Acute depletion of activated memory B cells involves the PD-1 pathway in rapidly progressing SIV-infected macaques.

Authors:  Kehmia Titanji; Vijayakumar Velu; Lakshmi Chennareddi; Matam Vijay-Kumar; Andrew T Gewirtz; Gordon J Freeman; Rama R Amara
Journal:  J Clin Invest       Date:  2010-10-25       Impact factor: 14.808

2.  Genetic characterization of HIV-1 from semen and blood from clade C-infected subjects from India and effect of therapy in these body compartments.

Authors:  Chengli Shen; Ming Ding; Jodi K Craigo; Patrick Tarwater; Ramdas Chatterjee; Pratima Roy; Subhasish K Guha; Bibhuti Saha; Dolonchapa Modak; Dhrubak Neogi; Yue Chen; Phalguni Gupta
Journal:  Virology       Date:  2010-03-15       Impact factor: 3.616

3.  Estimation of the predictive role of plasma viral load on CD4 decline in HIV-1 subtype C-infected subjects in India.

Authors:  Ming Ding; Patrick Tarwater; Milka Rodriguez; Ramdas Chatterjee; Deena Ratner; Yasuhiro Yamamura; Pratima Roy; John Mellors; Dhruba Neogi; Yue Chen; Phalguni Gupta
Journal:  J Acquir Immune Defic Syndr       Date:  2009-02-01       Impact factor: 3.731

4.  Highly complex neutralization determinants on a monophyletic lineage of newly transmitted subtype C HIV-1 Env clones from India.

Authors:  Smita S Kulkarni; Alan Lapedes; Haili Tang; S Gnanakaran; Marcus G Daniels; Ming Zhang; Tanmoy Bhattacharya; Ming Li; Victoria R Polonis; Francine E McCutchan; Lynn Morris; Dennis Ellenberger; Salvatore T Butera; Robert C Bollinger; Bette T Korber; Ramesh S Paranjape; David C Montefiori
Journal:  Virology       Date:  2009-01-23       Impact factor: 3.616

Review 5.  Impact of human immunodeficiency virus (HIV) subtypes on HIV-associated neurological disease.

Authors:  Kevin J Liner; Colin D Hall; Kevin R Robertson
Journal:  J Neurovirol       Date:  2007-08       Impact factor: 2.643

6.  Evident stabilization of the clinical profile in HIV/AIDS as evaluated in an open label clinical trial using a polyherbal formulation.

Authors:  Mangaiarkarasi Asokan; Imtiaz Nisar Lone; Anil Babu Mukthey; Paul Siddhartha; Gayathri Mariappa; Praveen Kumar Kotehal; Bhuthiah Satish; Eugene Wilson; Savariraj Sahayam; Gopinath Velayutham; Rajalakshmi Perumal; Karthikeyan Baskaran; Devanathan Rengarajan; Ravichandran Muthusamy; Mariamma Philip; K C Ravindra; Jeelan N Basha; Pushpak Mizar; Gurvinder Kaur; Narinder K Mehra; Tapas K Kundu; D K Subbakrishna; Kadappa Shivappa Satish; Udaykumar Ranga
Journal:  Indian J Med Res       Date:  2013-06       Impact factor: 2.375

7.  Disease progression by infecting HIV-1 subtype in a seroconverter cohort in sub-Saharan Africa.

Authors:  Pauli N Amornkul; Etienne Karita; Anatoli Kamali; Wasima N Rida; Eduard J Sanders; Shabir Lakhi; Matt A Price; William Kilembe; Emmanuel Cormier; Omu Anzala; Mary H Latka; Linda-Gail Bekker; Susan A Allen; Jill Gilmour; Patricia E Fast
Journal:  AIDS       Date:  2013-11-13       Impact factor: 4.177

8.  Exceptional molecular and coreceptor-requirement properties of molecular clones isolated from an Human Immunodeficiency Virus Type-1 subtype C infection.

Authors:  Prasanta K Dash; Nagadenahalli B Siddappa; Asokan Mangaiarkarasi; Aruna V Mahendarkar; Padmanabhan Roshan; Krishnamurthy Kumar Anand; Anita Mahadevan; Parthasarathy Satishchandra; Susarla K Shankar; Vinayaka R Prasad; Udaykumar Ranga
Journal:  Retrovirology       Date:  2008-03-07       Impact factor: 4.602

9.  Clinical prognostic value of RNA viral load and CD4 cell counts during untreated HIV-1 infection--a quantitative review.

Authors:  Eline L Korenromp; Brian G Williams; George P Schmid; Christopher Dye
Journal:  PLoS One       Date:  2009-06-17       Impact factor: 3.240

10.  Role of HIV-1 subtype C envelope V3 to V5 regions in viral entry, coreceptor utilization and replication efficiency in primary T-lymphocytes and monocyte-derived macrophages.

Authors:  Vasudha Sundaravaradan; Suman R Das; Rajesh Ramakrishnan; Shobha Sehgal; Sarla Gopalan; Nafees Ahmad; Shahid Jameel
Journal:  Virol J       Date:  2007-11-24       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.